In the final clip, James D. Chalmers, MBChB, PhD, notes that while the FDA approval of brensocatib is a milestone, questions remain on optimal patient selection, long-term benefits, and further ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback